000			01866ngm a2200397 a 4500
001			HST5208
003			UkLoHST
006			m c
007			cr|cna|||a||||
007			vz|czazum
008			210204s2021 enk|||||||||||s|||v|eng d
028	5	0	_a5208 _bHenry Stewart Talks
035			_a(UkLoHST)4491
040			_aUkLoHST _beng _cUkLoHST
100	1		_aPaul, Thomas A., _u(Pfizer, USA) _4spk
245	1	0	_aCancer-specific epigenetic alterations as investigated from a pharmaceutical perspective _h[electronic resource] / _cThomas A. Paul.
260			_aLondon : _bHenry Stewart Talks, _c2021.
300			_a1 online resource (1 streaming video file (34 min.) : _bcolor, sound).
490	1		_aThe biomedical & life sciences collection, _x2056-452X
500			_aAnimated audio-visual presentation with synchronized narration.
500			_aTitle from title frames.
505	0		_aContents: Chromatin dysregulation in cancer -- Features of epigenetic information in cells -- Mutated chromatin regulatory factors as tumor drivers -- Therapeutic rationale for the use of epigenetic drugs in oncology -- First generation epigenetic drugs: DNMT and HDAC inhibitors -- Novel therapeutic discoveries in oncology -- Biomarkers for patient selection.
506			_aAccess restricted to subscribers.
538			_aMode of access: World Wide Web.
650		0	_aAntineoplastic agents _xDevelopment.
650		0	_aCancer _xGenetic aspects.
650		0	_aEpigenesis.
650		2	_aAntineoplastic Agents _xpharmacology.
650		2	_aChromatin Assembly and Disassembly _xgenetics.
650		2	_aEpigenesis, Genetic.
650		2	_aHistone Deacetylase Inhibitors.
650		2	_aNeoplasms _xdrug therapy.
650		2	_aNeoplasms _xgenetics.
830		0	_aHenry Stewart talks. _pBiomedical & life sciences collection.
856	4	0	_uhttps://hstalks.com/bs/4491/
999			_c75850 _d75850